Factors Affecting Relapse and Remission in Behcet's Uveitis Treated with Interferon Alpha2a

---

Atıf İçin Kopyala

ÇELİKER ATABERK H., Kazokoglu H., Direskeneli H.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.35, sa.1, ss.58-65, 2018 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 35 Sayı: 1
• Basım Tarihi: 2018
• Doi Numarası: 10.1089/jop.2018.0083
• Dergi Adı: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.58-65
• Anahtar Kelimeler: Behcet disease, Behcet uveitis, IFN alpha 2a, interferons, relapse, uveitis, LONG-TERM EFFICACY, PROGNOSTIC-FACTORS, VISUAL PROGNOSIS, DISEASE, THERAPY, SAFETY, INFLIXIMAB, INVOLVEMENT, MANAGEMENT
• Marmara Üniversitesi Adresli: Evet

Özet

Purpose: To investigate factors affecting relapse and remission in patients with Behcet uveitis (BU) in the context of using the interferon alpha2a (IFN alpha 2a) therapy.